Literature DB >> 20697291

The use of probiotics in healthy volunteers with evacuation disorders and hard stools: a double-blind, randomized, placebo-controlled study.

Mario Del Piano1, Stefania Carmagnola, Andrea Anderloni, Silvano Andorno, Marco Ballarè, Marco Balzarini, Franco Montino, Marco Orsello, Michela Pagliarulo, Massimo Sartori, Roberto Tari, Filomena Sforza, Lucio Capurso.   

Abstract

BACKGROUND: Evacuation disorders and hard stools are common in industrialized countries, affecting on average 12% to 17% of the adult healthy population at any age. Dietary supplementation with probiotic microorganisms may be useful in reducing the disorder.
METHODS: We performed a double-blind, randomized, placebo-controlled study to evaluate the effectiveness of 2 different probiotic blends, either mixed Lactobacillus plantarum LP01 (LMG P-21021) and Bifidobacterium breve BR03 (DSM 16604) or Bifidobacterium animalis subspecies lactis BS01 (LMG P-21384), in the management of evacuation disorders and intestinal discomfort. In a period of 5 years (2003 to 2008), the study involved 300 healthy volunteers (151 males and 149 females; age 24 to 71 y) with evacuation disorders and hard stools. In particular, subjects were divided into 3 groups: 80 subjects in the group A received placebo, 110 subjects in the group B received mixed L. plantarum LP01 and B. breve BR03 (2.5 x 10 colony-forming units/d of each strain), and 110 subjects in the group C received B. animalis subsp. lactis BS01 (5 x 10 colony-forming units/d) for 30 days. At the beginning of the observational study, the healthy status of volunteers was evaluated by a complete, laboratory and ultrasound study of the abdomen. The physical examination was repeated after 15 and 30 days. In particular, the main troubles typically associated with evacuation disorders and hard stools as well as abdominal bloating were considered as parameters of interest. Exclusion criteria were items of gastrointestinal diseases and antibiotics intake.
RESULTS: Subjects treated with the mixed probiotic strains L. plantarum LP01 and B. breve BR03 or B. animalis subsp. lactis BS01 reported a significant improvement in the number of weekly bowel movements and in the main troubles associated with evacuations, particularly consistency of feces and ease of expulsion. Discomfort items such as abdominal bloating and anal itching, burning, or pain also registered a relevant improvement in the active groups receiving probiotics.
CONCLUSIONS: The intake of an effective amount of mixed L. plantarum LP01 and B. breve BR03 or B. animalis subsp. lactis BS01 for 30 days is able to significantly relieve the evacuation disorders and hard stools, thus providing a useful tool for the management of such condition, which is particularly widespread in industrialized countries at any age.

Entities:  

Mesh:

Year:  2010        PMID: 20697291     DOI: 10.1097/MCG.0b013e3181ee31c3

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

Review 1.  Chronic constipation: current treatment options.

Authors:  Louis Wing Cheong Liu
Journal:  Can J Gastroenterol       Date:  2011-10       Impact factor: 3.522

2.  Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial.

Authors:  Paula V P Guerra; Luiza N Lima; Tassia C Souza; Vanessa Mazochi; Francisco J Penna; Andreia M Silva; Jacques R Nicoli; Elizabet V Guimarães
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

Review 3.  Probiotics and prebiotics in intestinal health and disease: from biology to the clinic.

Authors:  Mary Ellen Sanders; Daniel J Merenstein; Gregor Reid; Glenn R Gibson; Robert A Rastall
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-11       Impact factor: 46.802

Review 4.  Intestinal microbiota and chronic constipation.

Authors:  Ying Zhao; Yan-Bo Yu
Journal:  Springerplus       Date:  2016-07-19

5.  Effects of Synbiotics among Constipated Adults in Serdang, Selangor, Malaysia-A Randomised, Double-Blind, Placebo-Controlled Trial.

Authors:  Ying Jye Lim; Rosita Jamaluddin; Abu Saad Hazizi; Jin Yu Chieng
Journal:  Nutrients       Date:  2018-06-26       Impact factor: 5.717

6.  Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence.

Authors:  Luca Magistrelli; Angela Amoruso; Luca Mogna; Teresa Graziano; Roberto Cantello; Marco Pane; Cristoforo Comi
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

7.  Is stool frequency associated with the richness and community composition of gut microbiota?

Authors:  Hye Jung Kwon; Jong Hyun Lim; Dongmin Kang; Sanghyun Lim; Seun Ja Park; Jae Hyun Kim
Journal:  Intest Res       Date:  2019-02-07

8.  Is a multispecies probiotic mixture effective in constipation during pregnancy? 'A pilot study'.

Authors:  Inge de Milliano; Merit M Tabbers; Joris A van der Post; Marc A Benninga
Journal:  Nutr J       Date:  2012-10-04       Impact factor: 3.271

9.  Differential Effects of Lactobacillus casei Strain Shirota on Patients With Constipation Regarding Stool Consistency in China.

Authors:  Shanbin Chen; Yangwenshan Ou; Liang Zhao; Yang Li; Zhenxing Qiao; Yanling Hao; Fazheng Ren
Journal:  J Neurogastroenterol Motil       Date:  2019-01-31       Impact factor: 4.924

10.  Isolation and Characterization of a Deoxynivalenol-Degrading Bacterium Bacillus licheniformis YB9 with the Capability of Modulating Intestinal Microbial Flora of Mice.

Authors:  Shiwei Wang; Qiuqiu Hou; Qianqian Guo; Jian Zhang; Yanmei Sun; Hong Wei; Lixin Shen
Journal:  Toxins (Basel)       Date:  2020-03-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.